Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
29.60
+0.50 (1.72%)
At close: Jul 20, 2026, 4:00 PM EDT
29.64
+0.04 (0.14%)
After-hours: Jul 20, 2026, 4:29 PM EDT
Oscar Health Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Oscar Health stock has a consensus rating of "Hold" and an average price target of $24.2. The average 1-year stock price forecast is 18.24% lower than the current stock price, while the lowest is $13 (-56.08%) and the highest is $35 (+18.24%).
Price Target: $24.2 (-18.24%)
Analyst Consensus: Hold
Price Target
Chart* Price targets were last updated on Jun 11, 2026.
Analyst Ratings
The average analyst rating for Oscar Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Hold | 5 | 5 | 6 | 7 | 7 | 7 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 2 | 2 | 1 | 1 | 0 | 0 |
| Total | 10 | 10 | 10 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Upgrades $30 → $35 | Buy | Upgrades | $30 → $35 | +18.24% | Jun 11, 2026 |
| Wells Fargo | Wells Fargo | Hold Upgrades $11 → $20 | Hold | Upgrades | $11 → $20 | -32.43% | Jun 4, 2026 |
Scott Fidel Goldman Sachs | Goldman Sachs | Hold Reiterates $17 → $22 | Hold | Reiterates | $17 → $22 | -25.68% | May 11, 2026 |
| Robert W. Baird | Robert W. Baird | Hold Maintains $15 → $19 | Hold | Maintains | $15 → $19 | -35.81% | May 7, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Maintains $11 → $13 | Sell | Maintains | $11 → $13 | -56.08% | May 7, 2026 |
Financial Forecast
Revenue This Year
18.54B
from 11.70B
Increased by 58.43%
Revenue Next Year
19.78B
from 18.54B
Increased by 6.69%
EPS This Year
1.10
from -1.69
EPS Next Year
1.51
from 1.10
Increased by 37.92%
EPS and Forward PE are based on non-GAAP adjusted numbers.